The global market for Automated Breast Ultrasound Systems (ABUS) was valued at US$972.1 Million in 2024 and is projected to reach US$2 Billion by 2030, growing at a CAGR of 13.2% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.
The design and functionality of ABUS have evolved to enhance user experience and patient comfort while maintaining high diagnostic accuracy. Modern ABUS machines are equipped with sophisticated software algorithms that analyze the ultrasound data to help differentiate between benign and malignant lesions, reducing the rate of false positives and the need for invasive biopsies. The systems are designed to scan the entire breast using a standardized approach, which minimizes the chance of missing areas of tissue that a manual ultrasound might overlook. Furthermore, ongoing advancements in ABUS technology focus on integrating artificial intelligence (AI) to improve image analysis capabilities. AI can assist radiologists by providing automated readings and highlighting areas of concern, which streamlines the workflow in busy clinical settings and may lead to more accurate assessments.
The growth in the Automated Breast Ultrasound Systems market is driven by several factors, including the rising global incidence of breast cancer, technological advancements in ultrasound imaging, and increasing awareness of the limitations of mammography in certain patient groups. As awareness of breast cancer screening increases, more women are seeking comprehensive screening solutions, particularly those who are identified as having dense breast tissue. Technological improvements in ABUS devices, such as enhanced imaging capabilities and the integration of AI, make these systems more appealing to healthcare providers by offering faster, more accurate readings and improving patient throughput. In addition, there is a growing demand for non-radiation-based diagnostic alternatives, which positions ABUS as a favorable option compared to traditional mammography, especially for younger women or those at higher risk of breast cancer. Regulatory bodies and healthcare organizations are also increasingly recommending supplementary ultrasound screening for women with dense breasts, further driving adoption of ABUS in clinical practices worldwide. These trends highlight the dynamic expansion of the ABUS market, fueled by both technological innovations and changing healthcare practices.
Global Automated Breast Ultrasound Systems (ABUS) Market - Key Trends and Drivers Summarized
Automated Breast Ultrasound Systems (ABUS) represent a significant advancement in imaging technology designed specifically for breast cancer screening. ABUS is used to obtain high-resolution ultrasound images of the breast, providing an effective supplementary tool alongside mammography, especially in women with dense breast tissue where mammography alone may not be as effective. This technology leverages high-frequency sound waves to produce detailed images of the breast tissue, aiding in the early detection of potentially cancerous lesions that may not be visible on mammograms. ABUS systems automate the imaging process, reducing operator dependency and variability, ensuring comprehensive coverage and consistency in imaging. This ability to consistently reproduce high-quality images makes ABUS a valuable tool in the early detection and ongoing monitoring of breast conditions, potentially leading to earlier diagnosis and treatment.The design and functionality of ABUS have evolved to enhance user experience and patient comfort while maintaining high diagnostic accuracy. Modern ABUS machines are equipped with sophisticated software algorithms that analyze the ultrasound data to help differentiate between benign and malignant lesions, reducing the rate of false positives and the need for invasive biopsies. The systems are designed to scan the entire breast using a standardized approach, which minimizes the chance of missing areas of tissue that a manual ultrasound might overlook. Furthermore, ongoing advancements in ABUS technology focus on integrating artificial intelligence (AI) to improve image analysis capabilities. AI can assist radiologists by providing automated readings and highlighting areas of concern, which streamlines the workflow in busy clinical settings and may lead to more accurate assessments.
The growth in the Automated Breast Ultrasound Systems market is driven by several factors, including the rising global incidence of breast cancer, technological advancements in ultrasound imaging, and increasing awareness of the limitations of mammography in certain patient groups. As awareness of breast cancer screening increases, more women are seeking comprehensive screening solutions, particularly those who are identified as having dense breast tissue. Technological improvements in ABUS devices, such as enhanced imaging capabilities and the integration of AI, make these systems more appealing to healthcare providers by offering faster, more accurate readings and improving patient throughput. In addition, there is a growing demand for non-radiation-based diagnostic alternatives, which positions ABUS as a favorable option compared to traditional mammography, especially for younger women or those at higher risk of breast cancer. Regulatory bodies and healthcare organizations are also increasingly recommending supplementary ultrasound screening for women with dense breasts, further driving adoption of ABUS in clinical practices worldwide. These trends highlight the dynamic expansion of the ABUS market, fueled by both technological innovations and changing healthcare practices.
Report Scope
The report analyzes the Automated Breast Ultrasound Systems (ABUS) market, presented in terms of market value (US$ Thousand). The analysis covers the key segments and geographic regions outlined below.Segments
System Type (Automated Breast Volume Scanner, Automated Breast Ultrasound System); End-Use (Hospitals End-Use, Diagnostics Imaging Laboratories End-Use, Specialty Centers End-Use).Geographic Regions/Countries
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.Key Insights:
- Market Growth: Understand the significant growth trajectory of the Automated Breast Volume Scanner segment, which is expected to reach US$1.1 Billion by 2030 with a CAGR of a 13%. The Automated Breast Ultrasound System segment is also set to grow at 13.4% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, valued at $262.2 Million in 2024, and China, forecasted to grow at an impressive 17.7% CAGR to reach $450.6 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of major players such as Canon Medical Systems Corporation, Delphinus Medical Technologies, Inc., Esaote SPA, GE HealthCare, Hologic, Inc and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Automated Breast Ultrasound Systems (ABUS) Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Automated Breast Ultrasound Systems (ABUS) Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global Automated Breast Ultrasound Systems (ABUS) Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Some of the 36 major companies featured in this Automated Breast Ultrasound Systems (ABUS) market report include:
- Canon Medical Systems Corporation
- Delphinus Medical Technologies, Inc.
- Esaote SPA
- GE HealthCare
- Hologic, Inc
- Mindray DS USA, Inc.
- Planmed Oy
- QView Medical
- Samsung Healthcare
- Siemens Healthineers NV/SA
- SonoCiné, Inc.
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERSIII. MARKET ANALYSISCANADAITALYSPAINRUSSIAREST OF EUROPESOUTH KOREAREST OF ASIA-PACIFICARGENTINABRAZILMEXICOREST OF LATIN AMERICAIRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EASTIV. COMPETITION
1. MARKET OVERVIEW
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
UNITED STATES
JAPAN
CHINA
EUROPE
FRANCE
GERMANY
UNITED KINGDOM
ASIA-PACIFIC
AUSTRALIA
INDIA
LATIN AMERICA
MIDDLE EAST
AFRICA
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Canon Medical Systems Corporation
- Delphinus Medical Technologies, Inc.
- Esaote SPA
- GE HealthCare
- Hologic, Inc
- Mindray DS USA, Inc.
- Planmed Oy
- QView Medical
- Samsung Healthcare
- Siemens Healthineers NV/SA
- SonoCiné, Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 270 |
| Published | February 2025 |
| Forecast Period | 2024 - 2030 |
| Estimated Market Value ( USD | $ 972.1 Million |
| Forecasted Market Value ( USD | $ 2000 Million |
| Compound Annual Growth Rate | 13.2% |
| Regions Covered | Global |
